Atish Choudhury, MD PhD
atishchoudhury.bsky.social
Atish Choudhury, MD PhD
@atishchoudhury.bsky.social
Medical Oncologist
Lank Center for Genitourinary Oncology
Dana-Farber Cancer Institute

Views expressed herein are my own
https://scholar.google.com/citations?user=sJ4jYT0AAAAJ&hl=en
Now activated! CLEARED will enroll pts with high-risk localized, lymph node-positive or low volume HSPC (planned for treatment interruption) to receive 2 years of relugolix+darolutamide for PK studies of the combo and to assess T recovery after completion. clinicaltrials.gov/study/NCT064...
ClinicalTrials.gov
clinicaltrials.gov
November 27, 2024 at 10:10 PM
See you at Kings Back Bay on Monday 11/25/24 from 6-10 pm for BellissiMO’s Movember Fundraising Finale. There will be food, karaoke, and celebration!
November 24, 2024 at 12:52 PM
Can oligometastatic prostate cancer be cured with "total therapy" including radiation to all sites of disease and hormonal therapy? Dr. Praful Ravi and I along with colleagues at Dana-Farber present data from our cohort. www.sciencedirect.com/science/arti...
Combined Fixed-duration Systemic Treatment and Metastasis-directed Radiotherapy for Oligometastatic Hormone-sensitive Prostate Cancer
It is unclear whether “total therapy” (androgen deprivation therapy [ADT] with or without an androgen receptor pathway inhibitor [ARPI], metastasis-di…
www.sciencedirect.com
November 24, 2024 at 12:29 PM